PA
SRRA

Perceptive Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Perceptive Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-66,655
Closed -$1.3M – 166
2021
Q2 		$1.3M Hold
66,655
– – 0.02% 140
2021
Q1 		$1.15M Hold
66,655
– – 0.01% 133
2020
Q4 		$1.07M Hold
66,655
– – 0.01% 133
2020
Q3 		$711K Hold
66,655
– – 0.01% 120
2020
Q2 		$807K Buy
66,655
+1
+0% +$12 0.01% 114
2020
Q1 		$664K Sell
66,654
-1
-0% -$13 0.02% 99
2019
Q4 		$910K Hold
66,655
– – 0.02% 97
2019
Q3 		$1.04M Hold
66,655
– – 0.03% 88
2019
Q2 		$1.49M Hold
66,655
– – 0.03% 86
2019
Q1 		$4.56M Hold
66,655
– – 0.13% 69
2018
Q4 		$3.41M Sell
66,655
-13,345
-17% -$852K 0.13% 69
2018
Q3 		$5.44M Sell
80,000
-32,500
-29% -$2.95M 0.15% 70
2018
Q2 		$13.3M Sell
112,500
-12,500
-10% -$1.25M 0.35% 54
2018
Q1 		$10.3M Hold
125,000
– – 0.29% 59
2017
Q4 		$18.6M Buy
125,000
+33,620
+37% +$3.23M 0.62% 45
2017
Q3 		$5.67M Hold
91,380
– – 0.22% 66
2017
Q2 		$4.28M Sell
91,380
-1,213
-1% -$61.9K 0.22% 69
2017
Q1 		$5.67M Buy
+92,593
New +$5.38M 0.32% 57

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors's SRRA Position: Q3 2021 in Review

Perceptive Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2021, closing a stake of 66,655 shares — an estimated $1.3M sold.

Perceptive Advisors first reported a position in SRRA in Q1 2017 and held it in 18 quarters. The position peaked at $18.6M in Q4 2017. 37 funds tracked by Wall St. Rank hold SRRA as of Q3 2021.

  • Perceptive Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Perceptive Advisors sold 66,655 Sierra Oncology, Inc. Common Stock shares in Q3 2021, an estimated $1.3M.
  • Perceptive Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2017 and held it in 18 quarters.
  • Perceptive Advisors's Sierra Oncology, Inc. Common Stock position peaked at $18.6M in Q4 2017.
  • 37 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2021.

Based on Perceptive Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.